메뉴 건너뛰기




Volumn 401, Issue 3, 2011, Pages 1023-1034

Development and validation of an HPLC-MS/MS method to quantify clopidogrel acyl glucuronide, clopidogrel acid metabolite, and clopidogrel in plasma samples avoiding analyte back-conversion

Author keywords

Back conversion; Clopidogrel; Clopidogrel acyl glucuronide; Liquid chromatography; Pharmacokinetics; Tandem mass spectrometry

Indexed keywords

ACCEPTANCE CRITERIA; ACCURATE ANALYSIS; ACID METABOLITES; ANALYTES; ANALYTICAL METHOD; ANALYTICAL PROCEDURE; AUTOSAMPLERS; BACK-CONVERSION; CLOPIDOGREL; EUROPEAN MEDICINES AGENCIES; FOOD AND DRUG ADMINISTRATION; GLUCURONIDES; HPLC-MS/MS; HUMAN PLASMA SAMPLES; HUMAN PLASMAS; ORDERS OF MAGNITUDE; PHARMACOKINETIC STUDIES; PLASMA SAMPLES; SIMULTANEOUS DETERMINATIONS; TANDEM MASS SPECTROMETRY;

EID: 80052579134     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-5147-4     Document Type: Article
Times cited : (49)

References (23)
  • 3
    • 1042298898 scopus 로고    scopus 로고
    • Determination of the carboxylic acid metabolite of clopidogrel in human plasma by liquid chromatography-electrospray ionization mass spectrometry
    • DOI 10.1016/S0003-2670(03)00019-9
    • A Mitakos I Panderi 2004 Anal Chim Acta 505 107 114 10.1016/S0003- 2670(03)00019-9 1:CAS:528:DC%2BD2cXhtVKntLk%3D (Pubitemid 38201414)
    • (2004) Analytica Chimica Acta , vol.505 , Issue.1 , pp. 107-114
    • Mitakos, A.1    Panderi, I.2
  • 13
    • 84856313768 scopus 로고    scopus 로고
    • Annual meeting
    • Havard G, Coulombe ME, Lachance S, Lévesque A, Massé R (2009) AAPS Journal 11 (S2). Annual meeting. Available at http://www.aapsj.org/ abstracts/AM-2009/AAPS2009-003196.pdf
    • (2009) AAPS Journal , vol.11 , Issue.S2
    • Havard, G.C.1
  • 14
    • 80052582141 scopus 로고    scopus 로고
    • Impact of unstable metabolites during drug quantification and specific evaluation of acyl glucuronide metabolites in bioanalysis
    • Nov 2009
    • Garofolo F (2009) Impact of unstable metabolites during drug quantification and specific evaluation of acyl glucuronide metabolites in bioanalysis. Lecture, AAPS Symposium, Nov 2009
    • (2009) Lecture, AAPS Symposium
    • Garofolo, F.1
  • 17
    • 0037663202 scopus 로고    scopus 로고
    • Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
    • DOI 10.1021/ac020361s
    • BK Matuszewski ML Constanzer CM Chavez-Eng 2003 Anal Chem 75 3019 3030 10.1021/ac020361s 1:CAS:528:DC%2BD3sXltV2jsL8%3D (Pubitemid 36830428)
    • (2003) Analytical Chemistry , vol.75 , Issue.13 , pp. 3019-3030
    • Matuszewski, B.K.1    Constanzer, M.L.2    Chavez-Eng, C.M.3
  • 19
    • 0032522993 scopus 로고    scopus 로고
    • Kinetic analysis by HPLC - Electrospray mass spectrometry of the pH- dependent acyl migration and solvolysis as the decomposition pathways of ifetroban 1-O-acyl glucuronide
    • DOI 10.1021/ac9708811
    • S Khan DS Teitz M Jemal 1998 Anal Chem 70 1622 1628 10.1021/ac9708811 (Pubitemid 28198476)
    • (1998) Analytical Chemistry , vol.70 , Issue.8 , pp. 1622-1628
    • Khan, S.1    Teitz, D.S.2    Jemal, M.3
  • 20
    • 0037306174 scopus 로고    scopus 로고
    • Acyl glucuronide drug metabolites: Toxicological and analytical implications
    • DOI 10.1097/00007691-200302000-00001
    • M Shipkova VW Armstrong M Oellerich E Wieland 2003 Ther Drug Monit 25 1 16 10.1097/00007691-200302000-00001 1:CAS:528:DC%2BD3sXmtVWgsA%3D%3D (Pubitemid 36139819)
    • (2003) Therapeutic Drug Monitoring , vol.25 , Issue.1 , pp. 1-16
    • Shipkova, M.1    Armstrong, V.W.2    Oellerich, M.3    Wieland, E.4
  • 22
    • 75149185863 scopus 로고    scopus 로고
    • 10.1002/bmc.1373 1:CAS:528:DC%2BD1MXhsF2jtrfO
    • M Jemal Z Ouyang YQ Xia 2010 Biomed Chromatogr 24 2 19 10.1002/bmc.1373 1:CAS:528:DC%2BD1MXhsF2jtrfO
    • (2010) Biomed Chromatogr , vol.24 , pp. 2-19
    • Jemal, M.1    Ouyang, Z.2    Xia, Y.Q.3
  • 23
    • 77955919081 scopus 로고    scopus 로고
    • European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP) Doc. Ref. EMEA/CHMP/EWP/192217/2009, Nov 2009
    • European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP) (2009) Guideline on validation of bioanalytical methods. Doc. Ref. EMEA/CHMP/EWP/192217/2009, Nov 2009
    • (2009) Guideline on Validation of Bioanalytical Methods


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.